MILFORD, Ohio and NEW SOUTH WALES, Australia, April 8, 2021 / PRNewswire / – Bionics control, a global assistive technology company specializing in speech generation devices, announced its partnership with Numotion, a leading provider of complex rehabilitation technology (CRT), which offers Control Bionics’ Trilogy product line. This partnership will expand access to those who can benefit from Control Bionics’ personalized augmentative and alternative communication (AAC) solutions.
Control Bionics’ products help people with a wide range of diagnoses, including ALS / MND, spinal muscular atrophy, cerebral palsy, and spinal cord injury. The Trilogy product line is a premier option in the broader AAC device category, providing a customizable solution that complements a patient’s capabilities as needs evolve over time, alongside industry-leading customer support. plan. “Control Bionics is passionate about helping customers find their ‘voice’ and take back control of their lives,” said Neale Java, CFO of Control Bionics. “We are delighted to partner with Numotion, a company established in the CRT space, to expand access to our life-changing multimodal communications solutions throughout the North East.
Although Numotion has more than 150 locations in the United States, this partnership will focus on the states of New Hampshire, Vermont, and new York to increase market awareness of the Control Bionics Trilogy speech generator device as well as its best neuroNode 3.0 sEMG (electromyography) + spatial sensor. This agreement is part of Control Bionics’ growth strategy to access the largest rehabilitation market and reinforces its commitment to provide cutting-edge solutions with access to all.
“The addition of Control Bionics’ Trilogy product line to our AAC device offering allows us to better serve those looking for flexible access methods and multimodal solutions,” said Amanda whipple, Director of augmentative communication at Numotion. “Their unique approach to AAC devices matches our desire to constantly improve and expand our offerings with cutting edge technology, thereby providing the greatest benefit to our customers in need.”
Appointments are now available to begin the evaluation process for Control Bionics products. Control Bionics and Numotion offer and support an extensive library of device loans for customers and their clinicians wishing to test the latter solution.
ABOUT CONTROL BIONICS (ASX: CBL): Control Bionics is a technical assistive device company that empowers people with communication challenges to participate more fully in daily life. Its augmentative and alternative communication (AAC) offerings help people with a variety of conditions find their ‘voice’. Control Bionics’ Trilogy product line is the only AAC harness product Three the modalities – tactile, visual and NeuroNode control – offering users the ultimate and personalized opportunity to express themselves. www.controlbionics.com
ABOUT NUMOTION: Numotion is the nation’s largest and largest provider of products and services that deliver mobility, health and personal independence. Our focus on Complex Rehabilitation Technology (CRT), urologic supplies, home accessibility, accessible vehicles and other assistive technologies help improve the lives of people with disabilities by enabling them to actively participate in the everyday life. CRTs are individually configured and medically necessary mobility products and services, including manual and power wheelchairs, designed to meet the unique medical and functional needs of people with significant disabilities and medical conditions in order to provide them with greater independence. www.numotion.com.
Bionics control contact: Emily boland
E-mail: [email protected]
Telephone: (513) 453-4848
Contact Numotion: Andrea Barnett
E-mail: [email protected]
Telephone: (615) 574-8815
SOURCE Bionics control